Fatal diabetic ketoacidosis and antipsychotic medication

21Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hyperglycemia and new onset diabetes have been described with certain antipsychotic medications and some of the initial presentations are fatal diabetic ketoacidosis (DKA). We report 17 deaths due to DKA in psychiatric patients treated with second generation antipsychotic medications. Death certificates and toxicology data were searched for DKA and hyperglycemia. We reviewed the medical examiner records which included the autopsy, toxicology, police, and medical examiner investigators' reports. The decedents ranged in age from 32 to 57 years (average 48 years). There were 15 men and two women. The immediate cause of death was DKA in all. The psychiatric disorders included: 10 schizophrenia, three bipolar/schizophrenia, two bipolar, and two major depression. The most frequent atypical antipsychotic medications found were quetiapine and olanzapine followed by risperidone. In 16 deaths, we considered the medication as primary or contributory to the cause of death. © 2012 American Academy of Forensic Sciences.

Cite

CITATION STYLE

APA

Ely, S. F., Neitzel, A. R., & Gill, J. R. (2013). Fatal diabetic ketoacidosis and antipsychotic medication. Journal of Forensic Sciences, 58(2), 398–403. https://doi.org/10.1111/1556-4029.12044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free